Half-normal Saline in Atrial Flutter Ablation

• Status: Completed
• Trial end date: 2021-01-31
• Target enrollment: 0
• Participant gender: All

Summary

To assess the acute and long-term efficacy of half-normal saline compared to normal saline for irrigation of open-irrigated catheters during catheter ablation for the treatment of cavotricuspid isthmus dependent atrial flutter.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sunnybrook Health Sciences Centre
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Patients > 18 years of age at the time of enrollment

• Patients presenting for right sided typical atrial flutter ablation who have a clinical indication to undergo catheter ablation

• Fully informed written informed consent by either the subject or subject's legal representative and ability for subject to comply with study responsibilities

Exclusion Criteria:

• The presence of thrombus within the left atrial appendage

• Prior catheter ablation of the cavotricuspid isthmus for right sided atrial flutter

• The inability to provide consent or comply with study requirements

• A predicted life expectancy of < 12 months